Uptake of PHMB in a bacterial nanocellulose-based wound dressing: A feasible clinical procedure

Ives Bernardelli de Mattos, Judith C.J. Holzer, Alexandru Cristian Tuca, Florian Groeber-Becker, Martin Funk, Daniel Popp, Selma Mautner, Thomas Birngruber, Lars Peter Kamolz

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: With the increase of antimicrobial resistance in recent decades, other methods of preventing and fighting infections must be considered. Burn patients, whose wound areas are often extensive, are especially prone to wound infections. The loading of bacterial nanocellulose (BNC) with antiseptics has already been successfully performed but unfortunately, the described procedure is time-consuming and thus not applicable in a clinical emergency setting. Therefore, a clinically feasible approach was established. Material and methods: Sheets of BNC-based wound dressings were placed into antiseptic solutions containing PHMB (Prontosan® and LAVANID® 2) and were left to soak for up to two hours. At different time points, samples were analysed for their concentration of PHMB and antiseptic efficacy. Results: Within 30 min, clinically relevant concentrations of PHMB were achieved in the BNC-based wound dressing. The 30-min PHMB uptake for Prontosan® and LAVANID® 2 resulted in concentrations of 0.05% and 0.019%, respectively. Samples from the PHMB loaded dressing showed a dose dependent antiseptic efficacy for Staphylococcus aureus. Conclusion: This experiment showed that the loading of BNC-based wound dressings with PHMB-containing antiseptics was achieved by a simple and quick procedure. According to studies a PHMB concentration of 0.001% can already inhibits all bacterial growth, indicating that the concentrations of PHMB in the BNC-based wound dressings after 30 min are higher than the minimal inhibitory concentration and the antiseptic efficacy after 120 min loading analysed by an standardized bacterial disk diffusion assay was shown to be comparable to the clinically used Suprasorb® X + PHMB wound dressing.

Original languageEnglish (US)
JournalBurns
DOIs
StateAccepted/In press - Jan 1 2018
Externally publishedYes

Fingerprint

Local Anti-Infective Agents
Bandages
Wounds and Injuries
Wound Infection
Staphylococcus aureus
Emergencies
Growth
Infection

Keywords

  • Antimicrobial wound dressing
  • Antiseptic uptake
  • BNC
  • Burn treatment
  • PHMB
  • Staphylococcus aureus

ASJC Scopus subject areas

  • Surgery
  • Emergency Medicine
  • Critical Care and Intensive Care Medicine

Cite this

de Mattos, I. B., Holzer, J. C. J., Tuca, A. C., Groeber-Becker, F., Funk, M., Popp, D., ... Kamolz, L. P. (Accepted/In press). Uptake of PHMB in a bacterial nanocellulose-based wound dressing: A feasible clinical procedure. Burns. https://doi.org/10.1016/j.burns.2018.10.023

Uptake of PHMB in a bacterial nanocellulose-based wound dressing : A feasible clinical procedure. / de Mattos, Ives Bernardelli; Holzer, Judith C.J.; Tuca, Alexandru Cristian; Groeber-Becker, Florian; Funk, Martin; Popp, Daniel; Mautner, Selma; Birngruber, Thomas; Kamolz, Lars Peter.

In: Burns, 01.01.2018.

Research output: Contribution to journalArticle

de Mattos, IB, Holzer, JCJ, Tuca, AC, Groeber-Becker, F, Funk, M, Popp, D, Mautner, S, Birngruber, T & Kamolz, LP 2018, 'Uptake of PHMB in a bacterial nanocellulose-based wound dressing: A feasible clinical procedure', Burns. https://doi.org/10.1016/j.burns.2018.10.023
de Mattos, Ives Bernardelli ; Holzer, Judith C.J. ; Tuca, Alexandru Cristian ; Groeber-Becker, Florian ; Funk, Martin ; Popp, Daniel ; Mautner, Selma ; Birngruber, Thomas ; Kamolz, Lars Peter. / Uptake of PHMB in a bacterial nanocellulose-based wound dressing : A feasible clinical procedure. In: Burns. 2018.
@article{1bab5617c1e248d38f8939cd7ada118e,
title = "Uptake of PHMB in a bacterial nanocellulose-based wound dressing: A feasible clinical procedure",
abstract = "Background: With the increase of antimicrobial resistance in recent decades, other methods of preventing and fighting infections must be considered. Burn patients, whose wound areas are often extensive, are especially prone to wound infections. The loading of bacterial nanocellulose (BNC) with antiseptics has already been successfully performed but unfortunately, the described procedure is time-consuming and thus not applicable in a clinical emergency setting. Therefore, a clinically feasible approach was established. Material and methods: Sheets of BNC-based wound dressings were placed into antiseptic solutions containing PHMB (Prontosan{\circledR} and LAVANID{\circledR} 2) and were left to soak for up to two hours. At different time points, samples were analysed for their concentration of PHMB and antiseptic efficacy. Results: Within 30 min, clinically relevant concentrations of PHMB were achieved in the BNC-based wound dressing. The 30-min PHMB uptake for Prontosan{\circledR} and LAVANID{\circledR} 2 resulted in concentrations of 0.05{\%} and 0.019{\%}, respectively. Samples from the PHMB loaded dressing showed a dose dependent antiseptic efficacy for Staphylococcus aureus. Conclusion: This experiment showed that the loading of BNC-based wound dressings with PHMB-containing antiseptics was achieved by a simple and quick procedure. According to studies a PHMB concentration of 0.001{\%} can already inhibits all bacterial growth, indicating that the concentrations of PHMB in the BNC-based wound dressings after 30 min are higher than the minimal inhibitory concentration and the antiseptic efficacy after 120 min loading analysed by an standardized bacterial disk diffusion assay was shown to be comparable to the clinically used Suprasorb{\circledR} X + PHMB wound dressing.",
keywords = "Antimicrobial wound dressing, Antiseptic uptake, BNC, Burn treatment, PHMB, Staphylococcus aureus",
author = "{de Mattos}, {Ives Bernardelli} and Holzer, {Judith C.J.} and Tuca, {Alexandru Cristian} and Florian Groeber-Becker and Martin Funk and Daniel Popp and Selma Mautner and Thomas Birngruber and Kamolz, {Lars Peter}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.burns.2018.10.023",
language = "English (US)",
journal = "Burns",
issn = "0305-4179",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Uptake of PHMB in a bacterial nanocellulose-based wound dressing

T2 - A feasible clinical procedure

AU - de Mattos, Ives Bernardelli

AU - Holzer, Judith C.J.

AU - Tuca, Alexandru Cristian

AU - Groeber-Becker, Florian

AU - Funk, Martin

AU - Popp, Daniel

AU - Mautner, Selma

AU - Birngruber, Thomas

AU - Kamolz, Lars Peter

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Background: With the increase of antimicrobial resistance in recent decades, other methods of preventing and fighting infections must be considered. Burn patients, whose wound areas are often extensive, are especially prone to wound infections. The loading of bacterial nanocellulose (BNC) with antiseptics has already been successfully performed but unfortunately, the described procedure is time-consuming and thus not applicable in a clinical emergency setting. Therefore, a clinically feasible approach was established. Material and methods: Sheets of BNC-based wound dressings were placed into antiseptic solutions containing PHMB (Prontosan® and LAVANID® 2) and were left to soak for up to two hours. At different time points, samples were analysed for their concentration of PHMB and antiseptic efficacy. Results: Within 30 min, clinically relevant concentrations of PHMB were achieved in the BNC-based wound dressing. The 30-min PHMB uptake for Prontosan® and LAVANID® 2 resulted in concentrations of 0.05% and 0.019%, respectively. Samples from the PHMB loaded dressing showed a dose dependent antiseptic efficacy for Staphylococcus aureus. Conclusion: This experiment showed that the loading of BNC-based wound dressings with PHMB-containing antiseptics was achieved by a simple and quick procedure. According to studies a PHMB concentration of 0.001% can already inhibits all bacterial growth, indicating that the concentrations of PHMB in the BNC-based wound dressings after 30 min are higher than the minimal inhibitory concentration and the antiseptic efficacy after 120 min loading analysed by an standardized bacterial disk diffusion assay was shown to be comparable to the clinically used Suprasorb® X + PHMB wound dressing.

AB - Background: With the increase of antimicrobial resistance in recent decades, other methods of preventing and fighting infections must be considered. Burn patients, whose wound areas are often extensive, are especially prone to wound infections. The loading of bacterial nanocellulose (BNC) with antiseptics has already been successfully performed but unfortunately, the described procedure is time-consuming and thus not applicable in a clinical emergency setting. Therefore, a clinically feasible approach was established. Material and methods: Sheets of BNC-based wound dressings were placed into antiseptic solutions containing PHMB (Prontosan® and LAVANID® 2) and were left to soak for up to two hours. At different time points, samples were analysed for their concentration of PHMB and antiseptic efficacy. Results: Within 30 min, clinically relevant concentrations of PHMB were achieved in the BNC-based wound dressing. The 30-min PHMB uptake for Prontosan® and LAVANID® 2 resulted in concentrations of 0.05% and 0.019%, respectively. Samples from the PHMB loaded dressing showed a dose dependent antiseptic efficacy for Staphylococcus aureus. Conclusion: This experiment showed that the loading of BNC-based wound dressings with PHMB-containing antiseptics was achieved by a simple and quick procedure. According to studies a PHMB concentration of 0.001% can already inhibits all bacterial growth, indicating that the concentrations of PHMB in the BNC-based wound dressings after 30 min are higher than the minimal inhibitory concentration and the antiseptic efficacy after 120 min loading analysed by an standardized bacterial disk diffusion assay was shown to be comparable to the clinically used Suprasorb® X + PHMB wound dressing.

KW - Antimicrobial wound dressing

KW - Antiseptic uptake

KW - BNC

KW - Burn treatment

KW - PHMB

KW - Staphylococcus aureus

UR - http://www.scopus.com/inward/record.url?scp=85057438107&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057438107&partnerID=8YFLogxK

U2 - 10.1016/j.burns.2018.10.023

DO - 10.1016/j.burns.2018.10.023

M3 - Article

C2 - 30509765

AN - SCOPUS:85057438107

JO - Burns

JF - Burns

SN - 0305-4179

ER -